Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study

KIKUKAWA Yoshitaka; YUKI Hiromichi; HIRATA Sinya; IDE Kazuhiko; NAKATA Hirotomo; MIYAKAWA Toshikazu; MATSUNO Naofumi; NOSAKA Kisato; YONEMURA Yuji; KAWAGUCHI Tatsuya; HATA Hiroyuki; MITSUYA Hiroaki; OKUNO Yutaka

Art

J-GLOBAL ID：201502297637026013 Reference number：15A0341897

Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study

ボルテゾミブ,シクロホスファミド,デキサメタゾンの併用はアミロイド軽鎖アミロイドーシスの日本人患者で良好な血液学的および臓器反応を誘導する:単一施設の後向き研究

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=15A0341897&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0341897&from=J-GLOBAL&jstjournalNo=F0888A") }}

Author (13)： , , , , , , , , , , , ,
Material：
Volume： 101 Issue： 2 Page： 133-139 Publication year： Feb. 2015
JST Material Number： F0888A ISSN： 0925-5710 CODEN： IJHEEY Document type： Article
Article type：原著論文 Country of issue： Germany, Federal Republic of (DEU) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0341897&from=J-GLOBAL&jstjournalNo=F0888A") }}

Drug therapy(=pharmacotherapy)for hematologic diseases in general

, ,

Reference (28)：

Kyle R, Linos A, Beard C, Linke R, Gertz M, O’Fallon W, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79:1817-22.
Dispenzieri A, Kyle R, Gertz M, Therneau T, Miller W, Chandrasekaran K, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003;361:1787-9.
Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Dingli D, et al. Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report. Leuk Lymphoma. 2010;51:2181-7.
Madan S, Kumar SK, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement. Blood. 2012;119:1117-22.
Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin GC, Buadi FK. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood. 2007;110:3561-3.

ｍore...

, , , , , , , , , , , , ,

Return to Previous Page